Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Mesocortical Dopamine Neurons

Lack of Autoreceptors Modulating Dopamine Synthesis

MICHAEL J. BANNON, RICHARD L. MICHAUD and ROBERT H. ROTH
Molecular Pharmacology March 1981, 19 (2) 270-275;
MICHAEL J. BANNON
Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RICHARD L. MICHAUD
Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ROBERT H. ROTH
Departments of Pharmacology and Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The regulation of dopamine (DA) synthesis in rat mesocortical DA neurons was studied and compared with DA synthesis in nigrostriatal DA neurons. The increase in striatal DA content caused by γ-butyrolactone (GBL) was reversed by activation of nerve-terminal DA autoreceptors by apomorphine. In contrast, the GBL-induced increase in prefrontal cortical DA was unaffected by DA agonists. By using the accumulation of dopa after the administration of the dopa decarboxylase inhibitor Ro4-4602 as an index of DA synthesis, it was demonstrated that the increase in striatal DA following GBL was due to an acceleration of DA synthesis. In contrast, GBL did not increase cortical dopa accumulation. However, GBL completely prevented the rapid decline of DA seen following α-methyltyrosine treatment, indicating that DA turnover had been inhibited in the mesocortical neurons, as has been previously demonstrated with other DA neurons. The monoamine oxidase inhibitor pargyline increased both striatal and cortical DA levels, leading to greatly attenuated dopa accumulation (tyrosine hydroxylation in vivo) in both regions. Finally, the DA antagonist haloperidol greatly accelerated striatal dopa accumulation, but effected only a modest change in cortical dopa accumulation, which was completely prevented by the GBL-induced inhibition of impulse flow. These results suggest that transmitter synthesis in the prefrontal cortical terminals of mesocortical DA neurons is subject to end product inhibition and is regulated by changes in neuronal impulse flow. However, the synthesis of DA in these terminals does not seem to be modulated by DA autoreceptors.

ACKNOWLEDGMENTS The authors gratefully acknowledge the assistance of Anne Morrison both in the development of the sample preparation procedure and in the routine processing of brain tissue samples. We thank Sarah Wheeler for her advice on the cortical dissection technique. We also thank Lynn Williams for her assistance in the preparation of the manuscript. The Ro4-4602 used in these experiments was generously supplied by Dr. Scott of Hoffmann-LaRoche.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 19, Issue 2
1 Mar 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mesocortical Dopamine Neurons
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Mesocortical Dopamine Neurons

MICHAEL J. BANNON, RICHARD L. MICHAUD and ROBERT H. ROTH
Molecular Pharmacology March 1, 1981, 19 (2) 270-275;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Mesocortical Dopamine Neurons

MICHAEL J. BANNON, RICHARD L. MICHAUD and ROBERT H. ROTH
Molecular Pharmacology March 1, 1981, 19 (2) 270-275;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics